Basic Information
| RNALocate ID: | RLID:11001344 |
| RNA Symbol: | hsa-miR-30d-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-30d-5p |
| RNA ID: | miRBase:MIMAT0000245 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23077538 |
| Tissue/Cell Line: | Plasma |
| Method: | Solexa sequencing |
| Description: | To characterize the stability of secreted miRNAs in plasma, we selected eight plasma miRNAs with relatively high copy numbers detected by Solexa sequencing (Table S1).Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001581 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001582 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001583 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001584 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001334 | Exosome | HCC tissues | 30542726 |
| RLID:11001335 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001336 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001337 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001338 | Exosome | Brain tissue | 23382797 |
| RLID:11001339 | Exosome | Plasma | 23663360 |
| RLID:11001340 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001341 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11001342 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001343 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001345 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001346 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000043 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000312 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30d-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37465 |
| MNDR | hsa-miR-30d-5p | Glomerulosclerosis | MNDR-E-MI-37466 |
| MNDR | hsa-miR-30d-5p | Oral squamous cell carcinoma | MNDR-E-MI-37467 |
| MNDR | hsa-miR-30d-5p | Large cell neuroendocrine cancer | MNDR-E-MI-37468 |
| MNDR | hsa-miR-30d-5p | Medulloblastoma | MNDR-E-MI-37469 |
| MNDR | hsa-miR-30d-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-37470 |
| MNDR | hsa-miR-30d-5p | Lymphoma | MNDR-E-MI-37471 |
| MNDR | hsa-miR-30d-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37472 |
| MNDR | hsa-miR-30d-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37473 |
| MNDR | hsa-miR-30d-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37474 |
| MNDR | hsa-miR-30d-5p | Niemann-pick disease type c | MNDR-E-MI-37475 |
| MNDR | hsa-miR-30d-5p | Anaplastic thyroid carcinoma | MNDR-E-MI-37476 |
| MNDR | hsa-miR-30d-5p | Dermatomyositis | MNDR-E-MI-37477 |
| MNDR | hsa-miR-30d-5p | Prostate cancer | MNDR-E-MI-37478 |
| MNDR | hsa-miR-30d-5p | Chronic lymphocytic leukemia | MNDR-E-MI-37479 |
| MNDR | hsa-miR-30d-5p | Gastric cancer | MNDR-E-MI-37480 |
| MNDR | hsa-miR-30d-5p | Gastric lymphoma | MNDR-E-MI-37481 |
| MNDR | hsa-miR-30d-5p | Alzheimer disease | MNDR-E-MI-37482 |
| MNDR | hsa-miR-30d-5p | Intracranial aneurysm | MNDR-E-MI-37483 |
| MNDR | hsa-miR-30d-5p | Esophageal carcinoma | MNDR-E-MI-37484 |
| MNDR | hsa-miR-30d-5p | Muscular dystrophy duchenne | MNDR-E-MI-37485 |
| MNDR | hsa-miR-30d-5p | Head and neck cancer | MNDR-E-MI-37486 |
| MNDR | hsa-miR-30d-5p | Primary biliary cirrhosis | MNDR-E-MI-37487 |
| MNDR | hsa-miR-30d-5p | Leukemia | MNDR-E-MI-37488 |
| MNDR | hsa-miR-30d-5p | Cardiovascular disease | MNDR-E-MI-37489 |
| MNDR | hsa-miR-30d-5p | Carotid stenosis | MNDR-E-MI-37490 |
| MNDR | hsa-miR-30d-5p | Lung cancer | MNDR-E-MI-37491 |
| MNDR | hsa-miR-30d-5p | Down syndrome | MNDR-E-MI-37492 |
| MNDR | hsa-miR-30d-5p | Parkinson disease | MNDR-E-MI-37493 |
| MNDR | hsa-miR-30d-5p | Niemann-pick disease | MNDR-E-MI-37494 |
| MNDR | hsa-miR-30d-5p | Basal-like breast cancer | MNDR-E-MI-37495 |
| MNDR | hsa-miR-30d-5p | Thyroid cancer | MNDR-E-MI-37496 |
| MNDR | hsa-miR-30d-5p | Pancreatic cancer | MNDR-E-MI-37497 |
| MNDR | hsa-miR-30d-5p | Melanoma | MNDR-E-MI-37498 |
| MNDR | hsa-miR-30d-5p | Rectum adenocarcinoma | MNDR-E-MI-37499 |
| MNDR | hsa-miR-30d-5p | Nephroblastoma | MNDR-E-MI-37500 |
| MNDR | hsa-miR-30d-5p | Colon cancer | MNDR-E-MI-37501 |
| MNDR | hsa-miR-30d-5p | Ischemic attack transient | MNDR-E-MI-37502 |
| MNDR | hsa-miR-30d-5p | Colon adenocarcinoma | MNDR-E-MI-37503 |
| MNDR | hsa-miR-30d-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37504 |
| MNDR | hsa-miR-30d-5p | Familial ovarian cancer | MNDR-E-MI-37505 |
| MNDR | hsa-miR-30d-5p | Prostate adenocarcinoma | MNDR-E-MI-37506 |
| MNDR | hsa-miR-30d-5p | Glioblastoma | MNDR-E-MI-37507 |
| MNDR | hsa-miR-30d-5p | Glioma | MNDR-E-MI-37508 |
| MNDR | hsa-miR-30d-5p | Chordoma | MNDR-E-MI-37509 |
| MNDR | hsa-miR-30d-5p | Temporal lobe epilepsy | MNDR-E-MI-37510 |
| MNDR | hsa-miR-30d-5p | Osteosarcoma | MNDR-E-MI-37511 |
| MNDR | hsa-miR-30d-5p | Inclusion body myositis | MNDR-E-MI-37512 |
| MNDR | hsa-miR-30d-5p | Liver cancer | MNDR-E-MI-37513 |
| MNDR | hsa-miR-30d-5p | Gastric adenocarcinoma | MNDR-E-MI-37514 |
| MNDR | hsa-miR-30d-5p | Cervical squamous cell carcinoma | MNDR-E-MI-37515 |
| MNDR | hsa-miR-30d-5p | Lung squamous cell carcinoma | MNDR-E-MI-37516 |
| MNDR | hsa-miR-30d-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37517 |
| MNDR | hsa-miR-30d-5p | Lung adenocarcinoma | MNDR-E-MI-37518 |
| MNDR | hsa-miR-30d-5p | Adrenocortical cancer | MNDR-E-MI-37519 |
| MNDR | hsa-miR-30d-5p | Thyroid carcinoma | MNDR-E-MI-37520 |
| MNDR | hsa-miR-30d-5p | Ovarian carcinoma | MNDR-E-MI-37521 |
| MNDR | hsa-miR-30d-5p | Bladder urothelial carcinoma | MNDR-E-MI-37522 |
| MNDR | hsa-miR-30d-5p | Pancreatic adenocarcinoma | MNDR-E-MI-37523 |
| MNDR | hsa-miR-30d-5p | Carcinoma renal cell | MNDR-E-MI-37524 |
| MNDR | hsa-miR-30d-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37525 |
| MNDR | hsa-miR-30d-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37526 |
| MNDR | hsa-miR-30d-5p | Large cell carcinoma | MNDR-E-MI-37527 |
| MNDR | hsa-miR-30d-5p | Biliary tract cancer | MNDR-E-MI-37528 |
| MNDR | hsa-miR-30d-5p | Cholangiocarcinoma | MNDR-E-MI-37529 |
| MNDR | hsa-miR-30d-5p | Esophageal cancer | MNDR-E-MI-37530 |
| MNDR | hsa-miR-30d-5p | Lung small cell carcinoma | MNDR-E-MI-37531 |
| MNDR | hsa-miR-30d-5p | Encephalopathy bovine spongiform | MNDR-E-MI-37532 |
| MNDR | hsa-miR-30d-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37533 |
| MNDR | hsa-miR-30d-5p | T acute lymphoblastic leukemia | MNDR-E-MI-37534 |
| MNDR | hsa-miR-30d-5p | Acute t cell leukemia | MNDR-E-MI-37535 |
| MNDR | hsa-miR-30d-5p | Heart failure | MNDR-E-MI-37536 |
| MNDR | hsa-miR-30d-5p | Fibromyalgia | MNDR-E-MI-37537 |
| MNDR | hsa-miR-30d-5p | Encephalomyelitis | MNDR-E-MI-37538 |
| MNDR | hsa-miR-30d-5p | Hepatocellular carcinoma | MNDR-E-MI-37539 |
| MNDR | hsa-miR-30d-5p | Familiar ovarian carcinoma | MNDR-E-MI-37540 |
| MNDR | hsa-miR-30d-5p | B-cell lymphoma | MNDR-E-MI-37541 |
| MNDR | hsa-miR-30d-5p | Rheumatoid arthritis | MNDR-E-MI-37542 |
| MNDR | hsa-miR-30d-5p | T-cell leukemia | MNDR-E-MI-37543 |
| MNDR | hsa-miR-30d-5p | Retinoblastoma | MNDR-E-MI-37544 |
| MNDR | hsa-miR-30d-5p | Burkitt lymphoma | MNDR-E-MI-37545 |
| MNDR | hsa-miR-30d-5p | Crohn disease | MNDR-E-MI-37546 |
| MNDR | hsa-miR-30d-5p | Tonsil cancer | MNDR-E-MI-37547 |
| MNDR | hsa-miR-30d-5p | Neuromyelitis optica | MNDR-E-MI-37548 |
| MNDR | hsa-miR-30d-5p | Acute myeloid leukemia | MNDR-E-MI-37549 |
| MNDR | hsa-miR-30d-5p | Colorectal cancer | MNDR-E-MI-37550 |
| MNDR | hsa-miR-30d-5p | Nasopharynx carcinoma | MNDR-E-MI-37551 |
| MNDR | hsa-miR-30d-5p | St elevation myocardial infarction | MNDR-E-MI-37552 |
| MNDR | hsa-miR-30d-5p | Cardiomegaly | MNDR-E-MI-37553 |
| MNDR | hsa-miR-30d-5p | Nasopharyngeal cancer | MNDR-E-MI-37554 |
| MNDR | hsa-miR-30d-5p | Sleep deprivation | MNDR-E-MI-37555 |
| MNDR | hsa-miR-30d-5p | Epstein-barr virus infections | MNDR-E-MI-37556 |
| MNDR | hsa-miR-30d-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37557 |
| MNDR | hsa-miR-30d-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37558 |
| MNDR | hsa-miR-30d-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37559 |
| MNDR | hsa-miR-30d-5p | Sarcopenia | MNDR-E-MI-37560 |
| MNDR | hsa-miR-30d-5p | Stroke lacunar | MNDR-E-MI-37561 |
| MNDR | hsa-miR-30d-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-37562 |
| MNDR | hsa-miR-30d-5p | Duke C | MNDR-E-MI-37563 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AC254633.1 | Homo sapiens | RR00032113 |
TOP